144 related articles for article (PubMed ID: 37983014)
61. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
[TBL] [Abstract][Full Text] [Related]
62. Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis.
Snyder MJ; Bentley R; Robboy SJ
Int J Gynecol Pathol; 2006 Apr; 25(2):155-60. PubMed ID: 16633065
[TBL] [Abstract][Full Text] [Related]
63. Ultrasound examination of the endometrium before and after Pipelle endometrial sampling.
Van den Bosch T; Van Schoubroeck D; Ameye L; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2005 Sep; 26(3):283-6. PubMed ID: 16082721
[TBL] [Abstract][Full Text] [Related]
64. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
65. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
[TBL] [Abstract][Full Text] [Related]
66. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
Yates MS; Meyer LA; Deavers MT; Daniels MS; Keeler ER; Mok SC; Gershenson DM; Lu KH
Cancer Prev Res (Phila); 2011 Mar; 4(3):463-70. PubMed ID: 21278312
[TBL] [Abstract][Full Text] [Related]
67. Magnetic resonance imaging findings of extrauterine high-grade serous carcinoma based on new pathologic criteria for primary site assignment.
Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Miyazaki T; Matsuo M
Acta Radiol; 2021 May; 62(5):687-694. PubMed ID: 32576024
[TBL] [Abstract][Full Text] [Related]
68. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
[TBL] [Abstract][Full Text] [Related]
69. Endometrial aspiration cytology for diagnosis of peritoneal lesions in extrauterine malignancies.
Saji H; Kurose K; Sugiura K; Miyagi E; Onose R; Kato H; Nakayama H
Acta Cytol; 2007; 51(4):533-40. PubMed ID: 17718117
[TBL] [Abstract][Full Text] [Related]
70. Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis.
Stewart CJ; Doherty DA; Havlat M; Koay MH; Leung YC; Naran A; O'Brien D; Ruba S; Salfinger S; Tan J
Pathology; 2013 Jun; 45(4):382-7. PubMed ID: 23635815
[TBL] [Abstract][Full Text] [Related]
71. [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].
Höhn AK; Einenkel J; Wittekind C; Horn LC
Pathologe; 2014 Jul; 35(4):322-6. PubMed ID: 24899496
[TBL] [Abstract][Full Text] [Related]
72. BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.
Sakamoto I; Hirotsu Y; Nakagomi H; Ouchi H; Ikegami A; Teramoto K; Amemiya K; Mochizuki H; Omata M
Cancer; 2016 Jan; 122(1):84-90. PubMed ID: 26439132
[TBL] [Abstract][Full Text] [Related]
73. Pipelle endometrial sampling in patients with known endometrial carcinoma.
Stovall TG; Photopulos GJ; Poston WM; Ling FW; Sandles LG
Obstet Gynecol; 1991 Jun; 77(6):954-6. PubMed ID: 2030877
[TBL] [Abstract][Full Text] [Related]
74. Is pipelle biopsy really adequate for diagnosing endometrial disease?
Tanriverdi HA; Barut A; Gün BD; Kaya E
Med Sci Monit; 2004 Jun; 10(6):CR271-4. PubMed ID: 15173672
[TBL] [Abstract][Full Text] [Related]
75. The presence of mucosal iron in the fallopian tube supports the "incessant menstruation hypothesis" for ovarian carcinoma.
Seidman JD
Int J Gynecol Pathol; 2013 Sep; 32(5):454-8. PubMed ID: 23896711
[TBL] [Abstract][Full Text] [Related]
76. Comparison of the histopathological diagnoses of preoperative dilatation and curettage and Pipelle biopsy.
Gungorduk K; Asicioglu O; Ertas IE; Ozdemir IA; Ulker MM; Yildirim G; Ataser G; Sanci M
Eur J Gynaecol Oncol; 2014; 35(5):539-43. PubMed ID: 25423700
[TBL] [Abstract][Full Text] [Related]
77. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
[TBL] [Abstract][Full Text] [Related]
78. Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.
Nishio S; Katsumata N; Matsumoto K; Tanabe H; Yonemori K; Kouno T; Shimizu C; Ando M; Kamura T; Kasamatsu T; Fujiwara Y
J Cancer Res Clin Oncol; 2009 Apr; 135(4):551-7. PubMed ID: 18830625
[TBL] [Abstract][Full Text] [Related]
79. Poor Prognostic Factors in Patients Undergoing Surgery After Neoadjuvant Chemotherapy for Ovarian, Tubal, or Peritoneal Cancer.
Kaban A; Topuz S; Saip P; Sozen H; Celebi K; Salihoglu Y
J Obstet Gynaecol Can; 2017 Dec; 39(12):1163-1170. PubMed ID: 28784563
[TBL] [Abstract][Full Text] [Related]
80. Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.
Bergsten TM; Burdette JE; Dean M
Cancer Lett; 2020 Apr; 476():152-160. PubMed ID: 32067992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
